Hepatitis c in the brazilian public health care system: burden of disease
| dc.creator | Adautocastelo | |
| dc.creator | Paulo Roberto Abrão Ferreira | |
| dc.creator | Carlos Eduardo Brandão Mello | |
| dc.creator | Rosangela Teixeira | |
| dc.creator | Jose Valdez Ramalho Madruga | |
| dc.creator | Tania Reuter | |
| dc.creator | Leila Maria Moreira Beltrão Pereira | |
| dc.creator | Giovanni Faria Silva | |
| dc.creator | Mario Reis Álvares-da-silva | |
| dc.creator | Heverton Zambrini | |
| dc.date.accessioned | 2024-01-11T22:45:21Z | |
| dc.date.accessioned | 2025-09-08T23:05:49Z | |
| dc.date.available | 2024-01-11T22:45:21Z | |
| dc.date.issued | 2018 | |
| dc.format.mimetype | ||
| dc.identifier.doi | 10.1590/s0004-2803.201800000-74 | |
| dc.identifier.issn | 16784219 | |
| dc.identifier.uri | https://hdl.handle.net/1843/62661 | |
| dc.language | eng | |
| dc.publisher | Universidade Federal de Minas Gerais | |
| dc.relation.ispartof | Arquivos de Gastroenterologia | |
| dc.rights | Acesso Aberto | |
| dc.subject | Hepatitis C | |
| dc.subject | Liver Cirrhosis | |
| dc.subject | Quality of life. | |
| dc.subject | Cost of Illness | |
| dc.subject.other | Hepatitis C | |
| dc.subject.other | Liver Cirrhosis | |
| dc.subject.other | Quality of life. | |
| dc.subject.other | Cost of Illness | |
| dc.title | Hepatitis c in the brazilian public health care system: burden of disease | |
| dc.type | Artigo de periódico | |
| local.citation.epage | 337 | |
| local.citation.issue | 4 | |
| local.citation.spage | 329 | |
| local.citation.volume | 55 | |
| local.description.resumo | Background – Infection by hepatitis C virus is one of the leading causes of chronic hepatitis C and cause severe burden for patients, families and the health care system. Objective – The aims of this research were to assess the severity of liver fibrosis, comorbidities and complications of hepatitis C virus; to examine health-related quality of life (HRQoL), productivity loss and resource use and costs in a sample of Brazilian chronic hepatitis C, genotype 1, patients. Methods – This was a cross-sectional multicenter study performed in genotype-1 chronic hepatitis C patients to assess disease burden in the Brazilian public health care system between November 2014 and March 2015. Patients were submitted to a liver transient elastography (FibroScan) to assess liver fibrosis and answered an interview composed by a questionnaire specifically developed for the study and three standardized questionnaires: EQ-5D-3L, HCV-PRO and WPAI:HepC. Results – There were 313 subjects enrolled, with predominance of women (50.8%), caucasian/white (55.9%) and employed individuals (39.9%). Mean age was 56 (SD=10.4) years old. Moreover, 42.8% of patients who underwent FibroScan were cirrhotic; the most frequent comorbidity was cardiovascular disease (62.6%) and the most frequent complication was esophageal varices (54.5%). The results also showed that “pain and discomfort” was the most affected HRQoL dimension (55.0% of patients reported some problems) and that the mean HCV-PRO overall score was 69.1 (SD=24.2). Regarding productivity loss, the most affected WPAI:HepC component was daily activity (23.5%) and among employed patients, presenteeism was more frequent than absenteeism (18.5% vs 6.5%). The direct medical costs in this chronic hepatitis C sample was 12,305.72USD per patient in the 2 years study period; drug treatment costs represented 95.9% of this total. Conclusion – This study showed that most patients are cirrhotic, present high prevalence of cardiometabolic diseases and esophageal varices, reducedHRQoL mainly in terms of pain/discomfort, and work productivity impairment, especially presenteeism. Additionally, we demonstrated that hepatitis C virus imposes an economic burden on Brazilian Health Care System and that most of this cost is due to drug treatmen. | |
| local.publisher.country | Brasil | |
| local.publisher.department | MED - DEPARTAMENTO DE CLÍNICA MÉDICA | |
| local.publisher.initials | UFMG | |
| local.url.externa | https://doi.org/10.1590/S0004-2803.201800000-74 |